Search research articles
Contact Us
Filters
Showing results (251-260 of 323) with videos related to
Page
of 33
Sort By:
Nuclear Medicine and Molecular Imaging
|
December 16, 2017
<sup>68</sup>Ga-PSMA PET/CT Imaging Predicting Intraprostatic Tumor Extent, Extracapsular Extension and Seminal Vesicle Invasion Prior to Radical Prostatectomy in Patients with Prostate Cancer
Christoph-Alexander J von Klot, Axel S Merseburger, Alena Böker, et al.
World Journal of Urology
|
September 22, 2018
SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer
Axel S Merseburger, Andrea B Apolo, Simon Chowdhury, et al.
Journal of Proteomics
|
December 31, 2013
Discovery and validation of urinary biomarkers for detection of renal cell carcinoma
Maria Frantzi, Jochen Metzger, Rosamonde E Banks, et al.
Oncotarget
|
October 21, 2017
Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention
Agnieszka Latosinska, Marika Mokou, Manousos Makridakis, et al.
European Urology Oncology
|
September 30, 2025
Apalutamide in Patients with High Burden of Metastatic Hormone-sensitive Prostate Cancer: A Subgroup Analysis of TITAN
Alejo Rodriguez-Vida, Angel Borque, Fernando Lopez-Campos, et al.
Oncology Reports
|
December 7, 2002
Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues
Axel S Merseburger, Markus A Kuczyk, Jurgen Serth, et al.
Critical Reviews in Oncology/Hematology
|
December 13, 2021
Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes
Ekaterina Laukhtina, Reza Sari Motlagh, Keiichiro Mori, et al.
Molecular Cancer Therapeutics
|
February 22, 2019
β-Arrestins Regulate Stem Cell-Like Phenotype and Response to Chemotherapy in Bladder Cancer
Georgios Kallifatidis, Diandra K Smith, Daley S Morera, et al.
The Journal of Urology
|
April 9, 2021
Safety and Efficacy of Atezolizumab in Understudied Populations with Pretreated Urinary Tract Carcinoma: Subgroup Analyses of the SAUL Study in Real-World Practice
Axel S Merseburger, Daniel Castellano, Thomas Powles, et al.
World Journal of Urology
|
March 3, 2023
Radiomics vs radiologist in prostate cancer. Results from a systematic review
Giuseppe Chiacchio, Daniele Castellani, Carlotta Nedbal, et al.
Page
of 33
Search research articles
Search
Showing results (251-260 of 323) with videos related to
Sort By:
Page
of 33
Nuclear Medicine and Molecular Imaging
|
December 16, 2017
<sup>68</sup>Ga-PSMA PET/CT Imaging Predicting Intraprostatic Tumor Extent, Extracapsular Extension and Seminal Vesicle Invasion Prior to Radical Prostatectomy in Patients with Prostate Cancer
Christoph-Alexander J von Klot, Axel S Merseburger, Alena Böker, et al.
World Journal of Urology
|
September 22, 2018
SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer
Axel S Merseburger, Andrea B Apolo, Simon Chowdhury, et al.
Journal of Proteomics
|
December 31, 2013
Discovery and validation of urinary biomarkers for detection of renal cell carcinoma
Maria Frantzi, Jochen Metzger, Rosamonde E Banks, et al.
Oncotarget
|
October 21, 2017
Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention
Agnieszka Latosinska, Marika Mokou, Manousos Makridakis, et al.
European Urology Oncology
|
September 30, 2025
Apalutamide in Patients with High Burden of Metastatic Hormone-sensitive Prostate Cancer: A Subgroup Analysis of TITAN
Alejo Rodriguez-Vida, Angel Borque, Fernando Lopez-Campos, et al.
Oncology Reports
|
December 7, 2002
Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues
Axel S Merseburger, Markus A Kuczyk, Jurgen Serth, et al.
Critical Reviews in Oncology/Hematology
|
December 13, 2021
Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes
Ekaterina Laukhtina, Reza Sari Motlagh, Keiichiro Mori, et al.
Molecular Cancer Therapeutics
|
February 22, 2019
β-Arrestins Regulate Stem Cell-Like Phenotype and Response to Chemotherapy in Bladder Cancer
Georgios Kallifatidis, Diandra K Smith, Daley S Morera, et al.
The Journal of Urology
|
April 9, 2021
Safety and Efficacy of Atezolizumab in Understudied Populations with Pretreated Urinary Tract Carcinoma: Subgroup Analyses of the SAUL Study in Real-World Practice
Axel S Merseburger, Daniel Castellano, Thomas Powles, et al.
World Journal of Urology
|
March 3, 2023
Radiomics vs radiologist in prostate cancer. Results from a systematic review
Giuseppe Chiacchio, Daniele Castellani, Carlotta Nedbal, et al.
Page
of 33